INVO Fertility (IVF) Stock Price, News & Analysis

Company Overview

NAYA Biosciences (NASDAQ: NAYA) is a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases, and fertility. Our hub & spoke model harnesses the shared resources of a parent company and agility of lean strategic franchises, enabling efficient acquisition, development, and partnering of assets as well as optimized return on investment by combining the upside of innovative clinical-stage therapeutics with scalable, profitable commercial revenues. NAYA’s expanding portfolio of assets currently includes NY-303, a GPC3 and NKp46 targeting bispecific antibody for the treatment of hepatocellular carcinoma (HCC) with a unique mode of action targeting non-responders to the current immunotherapy standard of care (approximately 70% of the current treatable market) cleared to enroll patients in a Phase I/II monotherapy trial in early 2025, NY-338, a CD38 and NKp46 targeting bispecific antibody for the treatment of multiple myeloma and autoimmune diseases with a differentiated safety and efficacy profile, and INVOcell®, an FDA-approved fertility device which has demonstrated comparable success rates to traditional In Vitro Fertilization (IVF).

Key Stats

• Today's Range: $0.84 to $0.87
• 50-Day Range: N/A
• 52-Week Range: $0.82 to $17.04
• Volume: 54,365 shs
• Average Volume: 567,932 shs
• Market Capitalization: $1.87 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

IVF Stock Analysis - Frequently Asked Questions

How have IVF shares performed this year?

INVO Fertility's stock was trading at $2.18 at the beginning of the year. Since then, IVF shares have decreased by 60.4% and is now trading at $0.8640.

How were INVO Fertility's earnings last quarter?

INVO Fertility, Inc (NASDAQ:IVF) announced its quarterly earnings results on Tuesday, May, 20th. The company reported ($12.53) EPS for the quarter. The firm earned $1.64 million during the quarter.

How do I buy shares of INVO Fertility?

Shares of IVF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 5/20/2025
• Today: 7/04/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:IVF
• CIK: 1417926
• Web: N/A
• Phone: (978) 878-9505
• Fax: N/A
• Employees: 10
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($34.06)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$9.10 million
• Net Margins: -377.73%
• Pretax Margin: -378.10%
• Return on Equity: N/A
• Return on Assets: -88.18%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.08
• Quick Ratio: 0.07

Sales & Book Value

• Annual Sales: $6.59 million
• Price / Sales: 0.28
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($29.86) per share
• Price / Book: -0.03

Miscellaneous

• Outstanding Shares: 2,161,000
• Free Float: 2,149,000
• Market Cap: $1.87 million
• Optionable: N/A
• Beta: 2.04